AJR Am J Roentgenol
-
Correction for "Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of
Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection".
AJR Am J Roentgenol. 2024 May 29:1. doi: 10.2214/AJR.24.31469.
Biochem Biophys Res Commun
- WANG B, Zhu X, Yu S, Xue H, et al
Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by
reducing hepatic steatosis and fibrosis in ob/ob mice.
Biochem Biophys Res Commun. 2024;722:150170.
- SHI X, Qi Z, Huang D, Zhu J, et al
HuR facilitates miR-93-5p-induced activation of MAP3K2 translation via MAP3K2
3'UTR ARE2 in hepatocellular carcinoma.
Biochem Biophys Res Commun. 2024;722:150152.
BMC Gastroenterol
- ELBADRY M, El-Raey F, Alboraie M, Abdel-Samiee M, et al
Clinical and endoscopic characteristics of patients undergoing gastrointestinal
endoscopic procedures in Egypt: a nationwide multicenter study.
BMC Gastroenterol. 2024;24:186.
Clin Res Hepatol Gastroenterol
- MANSUR A, Grobman B, Lu CY
Suicide risk is elevated among patients with chronic liver disease and cirrhosis
in the United States.
Clin Res Hepatol Gastroenterol. 2024;48:102378.
- CHANG G, Sun J, Li J, Li T, et al
Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic
Review and Meta-Analysis.
Clin Res Hepatol Gastroenterol. 2024 May 1:102361.
Dig Dis Sci
- ZHOU Y, Zhang Q, Kong Y, Guo X, et al
Retraction Note: Insulin-Like Growth Factor Binding Protein-Related Protein 1
Activates Primary Hepatic Stellate Cells via Autophagy Regulated by the
PI3K/Akt/mTOR Signaling Pathway.
Dig Dis Sci. 2024 May 29. doi: 10.1007/s10620-024-08506.
Endoscopy
- DHAR J, Bharath NP, Mahajan G, Bhujade H, et al
Bleeding parastomal varices in a case of decompensated cirrhosis with tubercular
abdominal cocoon: endoscopic ultrasound-guided angioembolization with coil and
glue to the rescue.
Endoscopy. 2024;56.
Eur Radiol
- LEWIN M
Can HCC postresection survival be predicted with prognostic MRI features?
Eur Radiol. 2024;34:3160-3162.
- MENDIRATTA-LALA M, Aslam A, Bai HX, Chapiro J, et al
Ethiodized oil as an imaging biomarker after conventional transarterial
chemoembolization.
Eur Radiol. 2024;34:3284-3297.
- ZENSEN S, Bucker A, Meetschen M, Haubold J, et al
Current use of percutaneous image-guided tumor ablation for the therapy of liver
tumors: lessons learned from the registry of the German Society for
Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022.
Eur Radiol. 2024;34:3322-3330.
- VOUCHE M
Large-scale data from real-life practice of percutaneous liver thermal ablation
from an international registry: unconditionally trustful Atlas or colossus with
feet of clay?
Eur Radiol. 2024;34:3320-3321.
Gastroenterology
- HANSCOM M
Magnetically guided capsule endoscopy comparable to EGD for detecting
esophagogastric varices in patients with cirrhosis.
Gastroenterology. 2024 May 28:S0016-5085(24)05001.
- HILSCHER MB, Wysokinski WE, Andrews JC, Simonetto DA, et al
Portal Vein Thrombosis in the Setting of Cirrhosis: Evaluation and Management
Strategies.
Gastroenterology. 2024 May 25:S0016-5085(24)04951.
Hepatology
- MANTOVANI S, Mondelli MU
Platelets harness innate immunity to promote dissemination of hepatocellular
carcinoma.
Hepatology. 2024 May 29. doi: 10.1097/HEP.0000000000000946.
- GUO C, Liu Z, Zhang T
Reply: Regarding the use of decision curve analysis in predicting long-term
complications of liver cirrhosis.
Hepatology. 2024 May 29. doi: 10.1097/HEP.0000000000000947.
- MUSSO G, Pinach S, Mariano F, Saba F, et al
Effect of phospholipid curcumin Meriva(R) on liver histology and kidney disease in
nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled
trial.
Hepatology. 2024 May 28. doi: 10.1097/HEP.0000000000000937.
Indian J Gastroenterol
- KULKARNI AV, Zuberi AA, Chaitanya K, Doolam H, et al
Human albumin infusion is safe and effective even in patients without acute
kidney injury and spontaneous bacterial peritonitis.
Indian J Gastroenterol. 2024;43:485-493.
- GUPTA E, Samal J, Maiwall R, Tevethia H, et al
Respiratory tract viral infections associated sepsis in patients with underlying
liver disease: Viral sepsis an entity to look forward!
Indian J Gastroenterol. 2024;43:475-484.
- SAMANTA A, Poddar U
Pediatric acute liver failure: Current perspective in etiology and management.
Indian J Gastroenterol. 2024;43:349-360.
- ZACHARIAH U, Vijayalekshmi B, Matthai SM, Goel A, et al
Extra-corporeal non-liver transplant therapies for acute liver failure: Focus on
plasma exchange and continuous renal replacement therapy.
Indian J Gastroenterol. 2024;43:338-348.
- SHARMA B, Bhateja A, Sharma R, Chauhan A, et al
Acute kidney injury in acute liver failure: A narrative review.
Indian J Gastroenterol. 2024;43:377-386.
- SEHRAWAT SS, Premkumar M
Critical care management of acute liver failure.
Indian J Gastroenterol. 2024;43:361-376.
- SINGH SA, Jadaun S, Gain A, Saigal S, et al
Difficult transplant decisions in acute liver failure -Benefit versus futility,
where to draw a line.
Indian J Gastroenterol. 2024;43:522-526.
- GIRI S, Anirvan P, Vaidya A, Praharaj DL, et al
Dengue-related acute liver failure-A scoping review.
Indian J Gastroenterol. 2024;43:407-424.
- SITHAMPARAPILLAI K, Zachariah U, Eapen CE, Goel A, et al
Plasma exchange improves survival in acute liver failure - An updated systematic
review and meta-analysis focussed on comparing within single etiology.
Indian J Gastroenterol. 2024;43:397-406.
- ALEXANDER V, Benjamin SJ, Subramani K, Sathyendra S, et al
Acute liver failure in pregnancy.
Indian J Gastroenterol. 2024;43:325-337.
- ACHARYA SK
Overview of acute liver failure in India.
Indian J Gastroenterol. 2024;43:296-311.
- GARG K, Jain AK, Nimje GR, Kajal K, et al
Perioperative care in acute liver failure: An anaesthesiologist perspective in
the operating theatre.
Indian J Gastroenterol. 2024;43:387-396.
J Clin Oncol
- SANGRO B, Galle PR, Kelley RK, Charoentum C, et al
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus
Durvalumab in Unresectable Hepatocellular Carcinoma.
J Clin Oncol. 2024 May 28:JCO2301462. doi: 10.1200/JCO.23.01462.
J Gastroenterol
- WAKABAYASHI SI, Tamaki N, Kimura T, Umemura T, et al
Natural history of lean and non-lean metabolic dysfunction-associated steatotic
liver disease.
J Gastroenterol. 2024;59:494-503.
- HIROOKA M, Ogawa S, Koizumi Y, Yoshida Y, et al
iATT liver fat quantification for steatosis grading by referring to MRI proton
density fat fraction: a multicenter study.
J Gastroenterol. 2024;59:504-514.
- MINO M, Sano A, Kakazu E, Matsubara H, et al
Differences in branched-chain amino acid to tyrosine ratio (BTR) among etiologies
of chronic liver disease progression compared to healthy adults.
J Gastroenterol. 2024;59:483-493.
J Gastroenterol Hepatol
- SHIN SK, Oh S, Chun SK, Ahn MJ, et al
Immune signature and therapeutic approach of natural killer cell in chronic liver
disease and hepatocellular carcinoma.
J Gastroenterol Hepatol. 2024 May 27. doi: 10.1111/jgh.16584.
- SUN Z, Guo Y, Xu X, Zhou C, et al
Hydronidone induces apoptosis in activated hepatic stellate cells through
endoplasmic reticulum stress-associated mitochondrial apoptotic pathway.
J Gastroenterol Hepatol. 2024 May 28. doi: 10.1111/jgh.16635.
J Hepatol
- ROY A, Tewari A, Sonthalia N, Chand Ghoshal U, et al
Identifying Predictors of Acute and Non-acute Decompensation in a Cohort of MASLD
Predominant Cirrhosis.
J Hepatol. 2024 May 24:S0168-8278(24)00363-5. doi: 10.1016/j.jhep.2024.
Minerva Gastroenterol (Torino)
- WANG Q, Chen X, Li H, Hua F, et al
Analysis of metabolic indexes in patients with type 2 diabetes and metabolic
associated fatty liver disease.
Minerva Gastroenterol (Torino). 2024;70:252-253.
N Engl J Med
- KOWDLEY KV, Levy C, Jones D
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
Reply.
N Engl J Med. 2024;390:1935-1936.
- HIRSCHFIELD GM, Kremer AE, Levy C
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
Reply.
N Engl J Med. 2024;390:1934-1935.
- IJICHI H
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
N Engl J Med. 2024;390:1934.
- AREVALO-CANAS C, Arevalo-Serrano J
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
N Engl J Med. 2024;390:1933-1934.
PLoS One
- SHI H, Xu H, Huang S, Tan Z, et al
Gender disparity between first and senior authors on liver cancer research in the
top journals of Gastroenterology and Hepatology.
PLoS One. 2024;19:e0295648.
- LU J, Feng Y, Guo K, Sun L, et al
Association between human blood metabolome and the risk of gastrointestinal
tumors.
PLoS One. 2024;19:e0304574.
Radiol Cardiothorac Imaging
- TANDON R, Agakishiev D, Freese RL, Thompson J, et al
Heart Rate Lowering for Coronary CTA with Ivabradine in End-Stage Liver Disease.
Radiol Cardiothorac Imaging. 2024;6:e230402.
Radiology
- LYSHCHIK A, Fetzer DT, Kono Y, Wilson SR, et al
Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation
Treatment Response Assessment Version 2024.
Radiology. 2024;311:e232369.
- MILOT L
Hepatocellular Carcinoma Assessment after Locoregional Treatment: A Primer on
LI-RADS Contrast-Enhanced Nonradiation Treatment Response Assessment Version
2024.
Radiology. 2024;311:e240124.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016